Linus Health offers a multimodal, smartphone- and tablet-based brain health solution that collects objective data from multiple digital measures of cognitive and motor function and translates that data into actionable insights. The platform aggregates digital biomarkers such as voice and speech patterns, visuospatial memory, dual-tasking ability, fine motor control, movement, balance, and pulmonary capacity. It enables care professionals to monitor brain health remotely and over extended periods of time, including outside clinical settings, and can link with electronic health records to provide a more comprehensive picture of an individual’s brain health. Researchers have used Linus’s assessments, including the DCTclock™ digital clock-drawing test, to identify early Alzheimer’s disease pathology in studies. The company is led by CEO David Bates and co-founder Alvaro Pascual-Leone, a behavioral neurologist and neuroscientist and Professor of Neurology at Harvard Medical School. Linus intends to use new funding to grow its team and accelerate development of its platform.

Total raised

$55M

Funding rounds

1

Latest round

Series B

Latest activity

Jul 2021